Contact this trialFirst, we need to learn more about you.
HIF-2alpha Inhibitor
Belzutifan + Cabozantinib for Kidney Cancer
Recruiting3 awardsPhase 2
Chattanooga, Tennessee
This trial will study the effects of two drugs, belzutifan and cabozantinib, when taken together by people with advanced kidney cancer. The drugs will be taken orally once daily.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service